More Post from the Author
- SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
- ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
- CGTN: Ako kultrne vmeny podporuj nsko-vietnamsk priatestvo
Stanley Black & Decker Announces 2nd Quarter 2025 Dividend
NEW BRITAIN, Conn., April 25, 2025 /PRNewswire/ -- Stanley Black & Decker (NYSE: SWK), a worldwide leader in Tools and Outdoor, announced today that its Board of Directors approved a regular second quarter cash dividend of $0.82 per common share. This extends the Company's record for the longest consecutive annual and quarterly dividend payments among industrial companies listed on the New York Stock Exchange. The dividend is payable on Tuesday, June 17, 2025, to shareholders of record as of the close of business on Tuesday, June 3, 2025.
About Stanley Black & Decker
Founded in 1843 and headquartered in the USA, Stanley Black & Decker (NYSE: SWK) is a worldwide leader in Tools and Outdoor, operating manufacturing facilities globally. The Company's approximately 48,000 employees produce innovative end-user inspired power tools, hand tools, storage, digital jobsite solutions, outdoor and lifestyle products, and engineered fasteners to support the world's builders, tradespeople and DIYers. The Company's world class portfolio of trusted brands includes DEWALT, CRAFTSMAN, STANLEY, BLACK+DECKER, and Cub Cadet. To learn more visit: www.stanleyblackanddecker.com or follow Stanley Black & Decker on Facebook, Instagram, LinkedIn andX.
Stanley Black & Decker Investor Contacts | |
Dennis Lange | Christina Francis |
Vice President, Investor Relations | Director, Investor Relations |
(860) 827-3833 | (860) 438-3470 |
SOURCE Stanley Black & Decker, Inc.

More Post from the Author
- SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
- ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
- CGTN: Ako kultrne vmeny podporuj nsko-vietnamsk priatestvo
